Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRESTO: A Phase III Randomised Controlled Trial of Dose-escalated Proton Beam Therapy Versus Standard of Care Radiotherapy for Functioning Pituitary Tumours

NCT07813351 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT07813351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07813351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRESTO: A Phase III Randomised Controlled Trial of Dose-escalated Proton Beam Therapy Versus Standard of Care Radiotherapy for Functioning Pituitary Tumours
Lead sponsor
University College, London
Phase
Phase 3
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
September 30, 2032
Enrollment
82 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acromegaly due to pituitary adenoma, cushing's disease, pituitary adenoma